QT Vascular gets FDA nod for balloon catheter
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
MEDICAL device provider QT Vascular announced yesterday that its wholly owned subsidiary TriReme Medical has received the approval of the US Food and Drug Administration (FDA) to market its Chocolate PTCA Balloon Catheter in the US.
This device, used in patients with coronary arterial disease, is used to dilate narrowed arteries in the heart, thus improving blood circulation there.
There is currently no clinical data available for the Chocolate PTCA.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
